I’d like to believe I leave this place a little less lonely, a little more just. - me. Immunology investor when I’m not fighting fascists.
Joined October 2009
- Tweets2.1K
- Following314
- Followers130
- Likes5.7K
Pinned Tweet
Still relevant, still fighting...
All You Fascists
Written by Woody Guthrie c. 1942
Sung by Billy Bragg and Wilco
youtu.be/dWBeGK96pVQ
“A majority” $PRTG @PortageBiotech
$PRTG @PortageBiotech some very good news coming out today at #ASCO2023. #iNkt “Several target lesions were substantially reduced in size or completely resolved, and a majority of target lesions being clinically stable after twelve weeks,” said Dr. Ian Walters.
$PRTG @PortageBiotech some very good news coming out today at #ASCO2023. #iNkt “Several target lesions were substantially reduced in size or completely resolved, and a majority of target lesions being clinically stable after twelve weeks,” said Dr. Ian Walters.
We’re pleased to share updated interim data on our lead #iNKT engager in a Phase 1/2 study for the treatment of #melanoma and #NSCLC at #ASCO23. For more details on the poster, click here: bit.ly/3qogjN0
$PRTG. @PortageBiotech We’ve been waiting a very long time for good news. The abstract certainly points to that. And while there were 2 CR, 1 PR, it’s the 10 SD. Is that something we’re gonna like? A lot? Hey Ian, would you host a q and a for investors after #ASCO?
$PRTG early stage in p1/p2 ,wont necessary see the press others receive,their abstract is worth a look
Strong early efficacy results at low/mid dose in their inkt agonist treating nsclc stage 4.
Patients had not repsonded to previous therapies and PD-1.
meetings.asco.org/abstracts-…
$PRTG. It’s a big deal!!
$PRTG “well tolerated” “no MTD was determined” “2 lesions completely resolved” we can’t forget these patients have sadly been through several other treatments that failed. Well done @PortageBiotech you seem to be improving outcomes with PORT2 🙏 #ASCO23 #CancerResearch
Just Us retweeted
Elmo had so much fun with the Haim sisters! @HAIMtheband, let Elmo know if you need a new member. "Elmo Haim" sounds pretty good to Elmo! Ha ha ha! ❤️
Just Us retweeted
Take a listen and realise the potential of $PRTG. At this price it's the bargain of the century. ASCO is weeks away where the data will prove the investment.
Check out this episode of @molecule2markt podcast, featuring our CEO Ian Walters! Ian discusses his background in the industry, along with Portage’s business model and progress in the clinic. Learn more about what makes Portage unique here: bit.ly/426vsA1
Just Us retweeted
CA is poised to be the 4th largest economy in the world, has the highest GDP of any state, & the most small businesses in the U.S.
At the @MilkenInstitute Global Conference, Governor @GavinNewsom highlighted CA's commitment to expanding freedom & economic opportunity for all.
$PRTG This is it! I know a number of investors have been waiting to see this. Coincides with the ASCO conference poster. We get solid update on IMM60 alone and in combo with Keytruda, I’ll be a very happy investor.
$PRTG Investors are at the start of data rolling in. ASCO in a June we get data on Port-2 alone and in combination with Keytruda. The cohort is small, larger trial starts June, more data at SITC in Nov. And funny, the trial was designed by Merck. This year could see a breakout.
$PRTG
Unlike other biotechs portage have designed import-201 trial to meet the exact clinical requirements $BMS & $MRK require. It helps when the chairman worked at BMS / brought nivolumab to market!
ir.portagebiotech.com/news-r…
Nice. We’ve been waiting for a few months for this. Looks robust across several continents. Big news in my mind. $PRTG @PortageBiotech @IntensityInc
$PRTG @PortageBiotech’s Adenosine, A2Bs, entering trial any day now. Good KOL to sign up for. Also, new trial on IMM60 and PEM, clinicaltrials.gov/ct2/show/… Lots finally moving with this one.